UK markets closed

Biofrontera Inc. (BFRI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.03000.0000 (0.00%)
As of 11:12AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-23,090
-20,131
-640
-37,713
-10,987
-
Depreciation & amortisation
1,105
1,064
1,172
540
562
-
Stock-based compensation
922
1,045
1,852
129
0
-
Change in working capital
-3,132
-4,394
2,788
-1,505
-2,827
-
Accounts receivable
421
-1,536
-70
-612
1,169
-
Inventory
-246
-3,750
-2,810
2,592
-273
-
Accounts payable
-
-
-
-773
-3,402
1,438
Other working capital
-24,579
-24,900
-16,237
-26,726
-12,369
-
Other non-cash items
-6,621
-6,883
-3,442
-1,044
498
-
Net cash provided by operating activities
-24,531
-24,895
-16,199
-26,715
-12,369
-
Cash flows from investing activities
Investments in property, plant and equipment
-48
-5
-38
-11
-
-538
Purchases of investments
-
0
-5,118
0
-
-
Sales/maturities of investments
681
624
0
-
-
-
Net cash used for investing activities
633
619
-5,156
-11
0
-
Cash flows from financing activities
Debt repayment
-22,850
-21,344
-
-
-
-
Common stock issued
-
4,507
9,391
29,938
0
-
Other financing activities
-
-
-
-
4,400
2,900
Net cash used provided by (used for) financing activities
14,210
8,411
14,021
43,191
13,194
-
Net change in cash
-9,688
-15,865
-7,334
16,465
825
-
Cash at beginning of period
13,705
17,408
24,742
8,277
7,452
-
Cash at end of period
4,017
1,543
17,408
24,742
8,277
-
Free cash flow
Operating cash flow
-24,531
-24,895
-16,199
-26,715
-12,369
-
Capital expenditure
-48
-5
-38
-11
-
-538
Free cash flow
-24,579
-24,900
-16,237
-26,726
-12,369
-